

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * cytidine deamination (GO:0009972) | 7.00850909 |
| 2 | * cytidine metabolic process (GO:0046087) | 7.00850909 |
| 3 | * cytidine catabolic process (GO:0006216) | 7.00850909 |
| 4 | * pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.23047297 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.71959360 |
| 6 | cellular response to interleukin-15 (GO:0071350) | 5.68117287 |
| 7 | * DNA deamination (GO:0045006) | 5.45326916 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.36175182 |
| 9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.35828033 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.15314056 |
| 11 | response to interleukin-15 (GO:0070672) | 5.13215562 |
| 12 | * regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.94945157 |
| 13 | negative T cell selection (GO:0043383) | 4.87216276 |
| 14 | positive thymic T cell selection (GO:0045059) | 4.83520313 |
| 15 | regulation of regulatory T cell differentiation (GO:0045589) | 4.77658058 |
| 16 | positive T cell selection (GO:0043368) | 4.73041401 |
| 17 | negative regulation of cell killing (GO:0031342) | 4.69230620 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.69230620 |
| 19 | T cell migration (GO:0072678) | 4.66732315 |
| 20 | positive regulation of B cell differentiation (GO:0045579) | 4.49918856 |
| 21 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.44772056 |
| 22 | negative thymic T cell selection (GO:0045060) | 4.38699123 |
| 23 | regulation of chronic inflammatory response (GO:0002676) | 4.36363178 |
| 24 | regulation of B cell differentiation (GO:0045577) | 4.35325020 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 4.32484340 |
| 26 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.27177140 |
| 27 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.27177140 |
| 28 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.25737806 |
| 29 | negative regulation by host of viral transcription (GO:0043922) | 4.23453393 |
| 30 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.20721839 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.20439026 |
| 32 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.10119103 |
| 33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.08444719 |
| 34 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.07403993 |
| 35 | thymic T cell selection (GO:0045061) | 4.04895809 |
| 36 | regulation of T cell tolerance induction (GO:0002664) | 4.04195521 |
| 37 | * negative regulation of viral genome replication (GO:0045071) | 4.02277503 |
| 38 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.01569408 |
| 39 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.98108673 |
| 40 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.93524590 |
| 41 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.90484113 |
| 42 | activated T cell proliferation (GO:0050798) | 3.90205538 |
| 43 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.90049104 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.85219737 |
| 45 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.84032014 |
| 46 | T cell selection (GO:0045058) | 3.81162528 |
| 47 | positive regulation of cell killing (GO:0031343) | 3.80178740 |
| 48 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.80042217 |
| 49 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.79926651 |
| 50 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.79403712 |
| 51 | negative regulation of B cell proliferation (GO:0030889) | 3.77749935 |
| 52 | positive regulation of lymphocyte migration (GO:2000403) | 3.75198113 |
| 53 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.73748200 |
| 54 | regulation of cell killing (GO:0031341) | 3.66347598 |
| 55 | negative regulation of T cell apoptotic process (GO:0070233) | 3.66263355 |
| 56 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.66151418 |
| 57 | T cell costimulation (GO:0031295) | 3.65946866 |
| 58 | lymphocyte costimulation (GO:0031294) | 3.62248951 |
| 59 | lymphocyte chemotaxis (GO:0048247) | 3.59982709 |
| 60 | interferon-gamma production (GO:0032609) | 3.58881421 |
| 61 | positive regulation of tolerance induction (GO:0002645) | 3.58623014 |
| 62 | immunoglobulin mediated immune response (GO:0016064) | 3.56190949 |
| 63 | B cell receptor signaling pathway (GO:0050853) | 3.53611205 |
| 64 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.53166932 |
| 65 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.50197873 |
| 66 | type I interferon signaling pathway (GO:0060337) | 3.50122420 |
| 67 | cellular response to type I interferon (GO:0071357) | 3.50122420 |
| 68 | response to type I interferon (GO:0034340) | 3.48048307 |
| 69 | T cell receptor signaling pathway (GO:0050852) | 3.44397641 |
| 70 | eosinophil chemotaxis (GO:0048245) | 3.43608176 |
| 71 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.43304910 |
| 72 | regulation of tolerance induction (GO:0002643) | 3.42787723 |
| 73 | regulation of T cell chemotaxis (GO:0010819) | 3.40939198 |
| 74 | positive regulation of T cell chemotaxis (GO:0010820) | 3.40939198 |
| 75 | response to interferon-beta (GO:0035456) | 3.40041838 |
| 76 | positive regulation of humoral immune response (GO:0002922) | 3.39734085 |
| 77 | regulation of activation of Janus kinase activity (GO:0010533) | 3.37634208 |
| 78 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.34212967 |
| 79 | negative regulation of T cell mediated immunity (GO:0002710) | 3.33684397 |
| 80 | actin nucleation (GO:0045010) | 3.26652662 |
| 81 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.25066010 |
| 82 | regulation of lymphocyte migration (GO:2000401) | 3.19847243 |
| 83 | B cell mediated immunity (GO:0019724) | 3.19357528 |
| 84 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.16702045 |
| 85 | lymphocyte migration (GO:0072676) | 3.13381878 |
| 86 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.12968255 |
| 87 | negative regulation of interleukin-12 production (GO:0032695) | 3.12606467 |
| 88 | leukocyte aggregation (GO:0070486) | 3.11058949 |
| 89 | eosinophil migration (GO:0072677) | 3.09670725 |
| 90 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.08730202 |
| 91 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.08411401 |
| 92 | negative regulation of B cell activation (GO:0050869) | 3.07389573 |
| 93 | cellular defense response (GO:0006968) | 3.06987262 |
| 94 | * pyrimidine nucleoside catabolic process (GO:0046135) | 3.06050361 |
| 95 | mast cell activation (GO:0045576) | 3.01829035 |
| 96 | NIK/NF-kappaB signaling (GO:0038061) | 2.98728582 |
| 97 | macrophage chemotaxis (GO:0048246) | 2.96469126 |
| 98 | * regulation of viral genome replication (GO:0045069) | 2.95757615 |
| 99 | chemokine-mediated signaling pathway (GO:0070098) | 2.94768678 |
| 100 | positive regulation of T cell mediated immunity (GO:0002711) | 2.94051524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.25423282 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.13381377 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.33466600 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.00132196 |
| 5 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.80479745 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.95363569 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.79988655 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.23828111 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.16016882 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.04764107 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.80387456 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.74038163 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.66365277 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.47820151 |
| 15 | MYB_26560356_Chip-Seq_TH1_Human | 2.42517513 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30845081 |
| 17 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.30702106 |
| 18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.26775355 |
| 19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.22567125 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.14492702 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.08572510 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.07368586 |
| 23 | GATA3_26560356_Chip-Seq_TH2_Human | 2.05993375 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.97086745 |
| 25 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.96073858 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.93434664 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 1.85390070 |
| 28 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.84819194 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83207204 |
| 30 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.81692794 |
| 31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80029266 |
| 32 | MAF_26560356_Chip-Seq_TH2_Human | 1.74211805 |
| 33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69253487 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.65640285 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.60391046 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.57257155 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.54832316 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50689248 |
| 39 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.49210604 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39636315 |
| 41 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.32952263 |
| 42 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32683293 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31221162 |
| 44 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.28623786 |
| 45 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26175608 |
| 46 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.22264270 |
| 47 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21963260 |
| 48 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.15130290 |
| 49 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.13850871 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.12883632 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12243285 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11143517 |
| 53 | GATA3_26560356_Chip-Seq_TH1_Human | 1.09862355 |
| 54 | MYC_22102868_ChIP-Seq_BL_Human | 1.07788547 |
| 55 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03905807 |
| 56 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.02697130 |
| 57 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.01848694 |
| 58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01272756 |
| 59 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00806261 |
| 60 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.00339920 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98736697 |
| 62 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.98379274 |
| 63 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.98124567 |
| 64 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.97966117 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96451161 |
| 66 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94543300 |
| 67 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.93528365 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89989722 |
| 69 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.88821895 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.88176896 |
| 71 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.87861253 |
| 72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.87011107 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86192692 |
| 74 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85461805 |
| 75 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.83590715 |
| 76 | VDR_22108803_ChIP-Seq_LS180_Human | 0.82553101 |
| 77 | P300_27268052_Chip-Seq_Bcells_Human | 0.82336055 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81747244 |
| 79 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.81638687 |
| 80 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.81249362 |
| 81 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80052596 |
| 82 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79882915 |
| 83 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.79193909 |
| 84 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79177829 |
| 85 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.77950950 |
| 86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77654749 |
| 87 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.76068424 |
| 88 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.75951366 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.75106630 |
| 90 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.74134300 |
| 91 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72610572 |
| 92 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.72136893 |
| 93 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.70939700 |
| 94 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.70836238 |
| 95 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.70803161 |
| 96 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.70176374 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.67435687 |
| 98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.67389734 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.67007540 |
| 100 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.66893770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.86942681 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.23627208 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.85420436 |
| 4 | MP0009785_altered_susceptibility_to | 3.72358859 |
| 5 | MP0001800_abnormal_humoral_immune | 3.47821934 |
| 6 | MP0001790_abnormal_immune_system | 3.43478272 |
| 7 | MP0005387_immune_system_phenotype | 3.43478272 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.34690683 |
| 9 | MP0000685_abnormal_immune_system | 3.19670800 |
| 10 | MP0006082_CNS_inflammation | 3.10596482 |
| 11 | MP0003436_decreased_susceptibility_to | 3.07246946 |
| 12 | MP0009333_abnormal_splenocyte_physiolog | 3.02662537 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 3.01105657 |
| 14 | MP0002723_abnormal_immune_serum | 2.95131930 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.85662712 |
| 16 | MP0005025_abnormal_response_to | 2.84277272 |
| 17 | MP0001873_stomach_inflammation | 2.80692622 |
| 18 | MP0001819_abnormal_immune_cell | 2.78674270 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.67633596 |
| 20 | MP0002398_abnormal_bone_marrow | 2.32712007 |
| 21 | MP0000716_abnormal_immune_system | 2.24796394 |
| 22 | MP0003724_increased_susceptibility_to | 2.24252762 |
| 23 | MP0002405_respiratory_system_inflammati | 2.23961127 |
| 24 | MP0002419_abnormal_innate_immunity | 2.20191796 |
| 25 | MP0002166_altered_tumor_susceptibility | 2.06220932 |
| 26 | MP0010155_abnormal_intestine_physiology | 2.05979255 |
| 27 | MP0000689_abnormal_spleen_morphology | 1.95444128 |
| 28 | MP0003866_abnormal_defecation | 1.94294203 |
| 29 | MP0000703_abnormal_thymus_morphology | 1.91809951 |
| 30 | MP0002722_abnormal_immune_system | 1.87898849 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.84240617 |
| 32 | MP0005310_abnormal_salivary_gland | 1.79565154 |
| 33 | MP0001853_heart_inflammation | 1.77570823 |
| 34 | MP0002429_abnormal_blood_cell | 1.77150147 |
| 35 | MP0003045_fibrosis | 1.63872741 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.61141253 |
| 37 | MP0002006_tumorigenesis | 1.58622932 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.53392045 |
| 39 | MP0002933_joint_inflammation | 1.50095243 |
| 40 | MP0004947_skin_inflammation | 1.49283805 |
| 41 | MP0008469_abnormal_protein_level | 1.41300487 |
| 42 | MP0009764_decreased_sensitivity_to | 1.39532718 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.32951002 |
| 44 | MP0003303_peritoneal_inflammation | 1.30766999 |
| 45 | MP0003448_altered_tumor_morphology | 1.25354740 |
| 46 | MP0002277_abnormal_respiratory_mucosa | 1.23048571 |
| 47 | MP0002163_abnormal_gland_morphology | 1.22781474 |
| 48 | MP0005075_abnormal_melanosome_morpholog | 1.19662002 |
| 49 | MP0004381_abnormal_hair_follicle | 1.16768772 |
| 50 | MP0009763_increased_sensitivity_to | 1.10967795 |
| 51 | MP0000372_irregular_coat_pigmentation | 1.07021556 |
| 52 | MP0003300_gastrointestinal_ulcer | 1.06761645 |
| 53 | MP0000569_abnormal_digit_pigmentation | 0.97117049 |
| 54 | MP0002693_abnormal_pancreas_physiology | 0.88027956 |
| 55 | MP0002019_abnormal_tumor_incidence | 0.87679990 |
| 56 | MP0001919_abnormal_reproductive_system | 0.85841544 |
| 57 | MP0009765_abnormal_xenobiotic_induced | 0.84552471 |
| 58 | MP0003786_premature_aging | 0.83651431 |
| 59 | MP0000858_altered_metastatic_potential | 0.83418351 |
| 60 | MP0005645_abnormal_hypothalamus_physiol | 0.80598070 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 0.79718156 |
| 62 | MP0001501_abnormal_sleep_pattern | 0.75667587 |
| 63 | MP0002132_abnormal_respiratory_system | 0.74933121 |
| 64 | MP0008873_increased_physiological_sensi | 0.71511159 |
| 65 | MP0005166_decreased_susceptibility_to | 0.70491609 |
| 66 | MP0001663_abnormal_digestive_system | 0.69542502 |
| 67 | MP0001348_abnormal_lacrimal_gland | 0.67826759 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 0.67466761 |
| 69 | MP0005379_endocrine/exocrine_gland_phen | 0.67175879 |
| 70 | MP0002396_abnormal_hematopoietic_system | 0.67005173 |
| 71 | MP0002876_abnormal_thyroid_physiology | 0.65459756 |
| 72 | MP0002998_abnormal_bone_remodeling | 0.65200161 |
| 73 | MP0003075_altered_response_to | 0.65083155 |
| 74 | MP0003183_abnormal_peptide_metabolism | 0.64532478 |
| 75 | MP0004510_myositis | 0.59908159 |
| 76 | MP0000015_abnormal_ear_pigmentation | 0.58497667 |
| 77 | MP0008872_abnormal_physiological_respon | 0.57775298 |
| 78 | MP0003195_calcinosis | 0.56888974 |
| 79 | MP0002136_abnormal_kidney_physiology | 0.54313436 |
| 80 | MP0003172_abnormal_lysosome_physiology | 0.53445833 |
| 81 | MP0005390_skeleton_phenotype | 0.51266622 |
| 82 | MP0003646_muscle_fatigue | 0.51208146 |
| 83 | MP0002095_abnormal_skin_pigmentation | 0.50756267 |
| 84 | MP0005174_abnormal_tail_pigmentation | 0.49526146 |
| 85 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.48018691 |
| 86 | MP0001986_abnormal_taste_sensitivity | 0.47537902 |
| 87 | MP0001851_eye_inflammation | 0.46787440 |
| 88 | MP0002168_other_aberrant_phenotype | 0.46686979 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 0.46150569 |
| 90 | MP0001765_abnormal_ion_homeostasis | 0.44643504 |
| 91 | MP0002254_reproductive_system_inflammat | 0.42480288 |
| 92 | MP0000604_amyloidosis | 0.41886526 |
| 93 | MP0009643_abnormal_urine_homeostasis | 0.41458152 |
| 94 | MP0003252_abnormal_bile_duct | 0.41369974 |
| 95 | MP0005389_reproductive_system_phenotype | 0.39998410 |
| 96 | MP0000490_abnormal_crypts_of | 0.38999240 |
| 97 | MP0005165_increased_susceptibility_to | 0.38479851 |
| 98 | MP0000371_diluted_coat_color | 0.37977125 |
| 99 | MP0003795_abnormal_bone_structure | 0.36164594 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 0.35922931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of T cell number (HP:0011839) | 6.54151748 |
| 2 | T lymphocytopenia (HP:0005403) | 6.44216977 |
| 3 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.42903754 |
| 4 | Autoimmune hemolytic anemia (HP:0001890) | 5.17422006 |
| 5 | Abnormality of T cells (HP:0002843) | 4.98870125 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.98609200 |
| 7 | Increased IgM level (HP:0003496) | 4.68163685 |
| 8 | IgG deficiency (HP:0004315) | 4.64897218 |
| 9 | Stomatitis (HP:0010280) | 4.47331862 |
| 10 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.28815337 |
| 11 | Recurrent cutaneous fungal infections (HP:0011370) | 4.28815337 |
| 12 | Meningitis (HP:0001287) | 4.19374983 |
| 13 | Severe combined immunodeficiency (HP:0004430) | 4.17344992 |
| 14 | Agammaglobulinemia (HP:0004432) | 4.01682316 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.99079696 |
| 16 | Recurrent bronchitis (HP:0002837) | 3.98112823 |
| 17 | Encephalitis (HP:0002383) | 3.95062543 |
| 18 | Myositis (HP:0100614) | 3.91587547 |
| 19 | Optic neuritis (HP:0100653) | 3.88820818 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.88820818 |
| 21 | Abnormality of eosinophils (HP:0001879) | 3.88390273 |
| 22 | Aplastic anemia (HP:0001915) | 3.87813636 |
| 23 | Chronic diarrhea (HP:0002028) | 3.83093382 |
| 24 | Vasculitis (HP:0002633) | 3.81435856 |
| 25 | Pulmonary infiltrates (HP:0002113) | 3.70269548 |
| 26 | Abnormality of T cell physiology (HP:0011840) | 3.66437854 |
| 27 | Orchitis (HP:0100796) | 3.64911474 |
| 28 | Recurrent viral infections (HP:0004429) | 3.64065590 |
| 29 | Eosinophilia (HP:0001880) | 3.51051296 |
| 30 | Panhypogammaglobulinemia (HP:0003139) | 3.47118567 |
| 31 | Abnormality of macrophages (HP:0004311) | 3.46996586 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 3.45840121 |
| 33 | Hypoproteinemia (HP:0003075) | 3.39807790 |
| 34 | Leukocytosis (HP:0001974) | 3.32443326 |
| 35 | Abnormality of the prostate (HP:0008775) | 3.32165287 |
| 36 | Combined immunodeficiency (HP:0005387) | 3.29288678 |
| 37 | Thyroiditis (HP:0100646) | 3.25228588 |
| 38 | Recurrent bacterial skin infections (HP:0005406) | 3.23904246 |
| 39 | Mediastinal lymphadenopathy (HP:0100721) | 3.23175033 |
| 40 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.22387123 |
| 41 | Gastrointestinal infarctions (HP:0005244) | 3.21356406 |
| 42 | Chronic obstructive pulmonary disease (HP:0006510) | 3.20032199 |
| 43 | Obstructive lung disease (HP:0006536) | 3.20032199 |
| 44 | Recurrent skin infections (HP:0001581) | 3.19593404 |
| 45 | Granulocytopenia (HP:0001913) | 3.18377702 |
| 46 | Lymphopenia (HP:0001888) | 3.16082381 |
| 47 | Hemoptysis (HP:0002105) | 3.08316158 |
| 48 | Recurrent abscess formation (HP:0002722) | 3.07318264 |
| 49 | IgM deficiency (HP:0002850) | 2.99245221 |
| 50 | Eczematoid dermatitis (HP:0000976) | 2.86988619 |
| 51 | Chest pain (HP:0100749) | 2.83757904 |
| 52 | Gangrene (HP:0100758) | 2.83698407 |
| 53 | Keratoconjunctivitis sicca (HP:0001097) | 2.82002120 |
| 54 | Joint swelling (HP:0001386) | 2.80788188 |
| 55 | Keratoconjunctivitis (HP:0001096) | 2.79773979 |
| 56 | Abnormality of B cell number (HP:0010975) | 2.78046964 |
| 57 | Abnormality of the pleura (HP:0002103) | 2.72732018 |
| 58 | Pustule (HP:0200039) | 2.65083463 |
| 59 | Hypergammaglobulinemia (HP:0010702) | 2.63829101 |
| 60 | IgA deficiency (HP:0002720) | 2.63523867 |
| 61 | Hypoplasia of the thymus (HP:0000778) | 2.49610514 |
| 62 | Pulmonary embolism (HP:0002204) | 2.48514121 |
| 63 | Lymphoma (HP:0002665) | 2.47528186 |
| 64 | B lymphocytopenia (HP:0010976) | 2.39224295 |
| 65 | Skin rash (HP:0000988) | 2.37409311 |
| 66 | Bronchitis (HP:0012387) | 2.37323793 |
| 67 | Pulmonary fibrosis (HP:0002206) | 2.33408229 |
| 68 | Ureteral stenosis (HP:0000071) | 2.24270134 |
| 69 | Hypochromic anemia (HP:0001931) | 2.17171393 |
| 70 | Arterial thrombosis (HP:0004420) | 2.15884068 |
| 71 | Inflammation of the large intestine (HP:0002037) | 2.14742377 |
| 72 | Recurrent sinusitis (HP:0011108) | 2.12490642 |
| 73 | Ureteral obstruction (HP:0006000) | 2.11481055 |
| 74 | Urticaria (HP:0001025) | 2.11114514 |
| 75 | Anorexia (HP:0002039) | 2.09451102 |
| 76 | Acute hepatic failure (HP:0006554) | 2.08428894 |
| 77 | Polyneuropathy (HP:0001271) | 2.08418518 |
| 78 | Abnormality of the pericardium (HP:0001697) | 2.03425494 |
| 79 | Abnormality of male internal genitalia (HP:0000022) | 2.02437073 |
| 80 | Glomerulopathy (HP:0100820) | 1.98019393 |
| 81 | Chronic otitis media (HP:0000389) | 1.95934101 |
| 82 | Gastrointestinal inflammation (HP:0004386) | 1.94867553 |
| 83 | Hemiplegia (HP:0002301) | 1.94284216 |
| 84 | Alveolar cell carcinoma (HP:0006519) | 1.93748097 |
| 85 | Gastrointestinal stroma tumor (HP:0100723) | 1.92109442 |
| 86 | Keratitis (HP:0000491) | 1.91671033 |
| 87 | Increased IgE level (HP:0003212) | 1.91153536 |
| 88 | 3-Methylglutaconic aciduria (HP:0003535) | 1.90104550 |
| 89 | Abnormal albumin level (HP:0012116) | 1.87444726 |
| 90 | Hypoalbuminemia (HP:0003073) | 1.87444726 |
| 91 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.85934522 |
| 92 | Colitis (HP:0002583) | 1.85907292 |
| 93 | Epistaxis (HP:0000421) | 1.80157826 |
| 94 | Recurrent otitis media (HP:0000403) | 1.79402917 |
| 95 | Neutropenia (HP:0001875) | 1.78573829 |
| 96 | Arthralgia (HP:0002829) | 1.76290344 |
| 97 | Restrictive lung disease (HP:0002091) | 1.75184233 |
| 98 | Petechiae (HP:0000967) | 1.74842354 |
| 99 | Oral leukoplakia (HP:0002745) | 1.71402546 |
| 100 | Verrucae (HP:0200043) | 1.69635553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 7.97531183 |
| 2 | MAP4K1 | 4.61053069 |
| 3 | KDR | 3.27510680 |
| 4 | TAOK3 | 2.79835795 |
| 5 | RIPK4 | 2.70189683 |
| 6 | FES | 2.60078130 |
| 7 | ITK | 2.49848903 |
| 8 | CSK | 2.18832346 |
| 9 | SYK | 2.16980660 |
| 10 | TLK1 | 2.00267859 |
| 11 | IKBKE | 1.93296763 |
| 12 | TESK2 | 1.87119435 |
| 13 | IKBKB | 1.82155940 |
| 14 | JAK3 | 1.78142690 |
| 15 | BTK | 1.77318772 |
| 16 | BLK | 1.74739060 |
| 17 | LCK | 1.72696528 |
| 18 | MST4 | 1.70628164 |
| 19 | ADRBK2 | 1.67406562 |
| 20 | BCKDK | 1.66399043 |
| 21 | PRKCQ | 1.64087994 |
| 22 | IRAK4 | 1.58452925 |
| 23 | GRK7 | 1.57057434 |
| 24 | TYK2 | 1.56873819 |
| 25 | MAP3K14 | 1.54349651 |
| 26 | TNK2 | 1.52465325 |
| 27 | ZAP70 | 1.50727141 |
| 28 | TBK1 | 1.49648071 |
| 29 | JAK1 | 1.44461813 |
| 30 | LYN | 1.41257382 |
| 31 | TEC | 1.37379664 |
| 32 | BMPR2 | 1.35740726 |
| 33 | KIT | 1.35479194 |
| 34 | GRK6 | 1.30956445 |
| 35 | NUAK1 | 1.30700721 |
| 36 | CSF1R | 1.24258115 |
| 37 | PIK3CA | 1.15190369 |
| 38 | MAP3K11 | 1.12666976 |
| 39 | EIF2AK3 | 1.09924877 |
| 40 | MATK | 1.06148282 |
| 41 | HCK | 1.03699865 |
| 42 | FRK | 0.99533814 |
| 43 | JAK2 | 0.98784037 |
| 44 | STK10 | 0.96031639 |
| 45 | MAP2K6 | 0.94405973 |
| 46 | ZAK | 0.85395101 |
| 47 | CAMKK2 | 0.81643925 |
| 48 | MARK3 | 0.76677228 |
| 49 | VRK1 | 0.70680086 |
| 50 | EPHA3 | 0.70576246 |
| 51 | MAP4K2 | 0.70176313 |
| 52 | PIM1 | 0.68242919 |
| 53 | ACVR1B | 0.66671078 |
| 54 | ERN1 | 0.66175097 |
| 55 | FYN | 0.63258647 |
| 56 | PIK3CG | 0.62003969 |
| 57 | MAPKAPK3 | 0.60877506 |
| 58 | GRK1 | 0.60641936 |
| 59 | CHUK | 0.58197368 |
| 60 | MAP3K13 | 0.57933885 |
| 61 | MAP3K12 | 0.57775534 |
| 62 | MAPK11 | 0.56135739 |
| 63 | SIK3 | 0.55563966 |
| 64 | PDK1 | 0.53779303 |
| 65 | VRK2 | 0.50011736 |
| 66 | RPS6KA5 | 0.49709790 |
| 67 | CLK1 | 0.47757163 |
| 68 | BMPR1B | 0.46424487 |
| 69 | PRKCH | 0.45443358 |
| 70 | IRAK1 | 0.45248292 |
| 71 | FGR | 0.44602074 |
| 72 | IGF1R | 0.44562623 |
| 73 | NLK | 0.44449995 |
| 74 | TYRO3 | 0.44414155 |
| 75 | TGFBR2 | 0.43798739 |
| 76 | DAPK2 | 0.41879469 |
| 77 | MAPKAPK2 | 0.39805360 |
| 78 | FGFR4 | 0.39475650 |
| 79 | INSR | 0.39118923 |
| 80 | MAP3K5 | 0.36844742 |
| 81 | HIPK2 | 0.36121251 |
| 82 | MAP2K3 | 0.32628808 |
| 83 | DAPK1 | 0.31780090 |
| 84 | FGFR3 | 0.31434442 |
| 85 | PRKCD | 0.28825050 |
| 86 | WNK4 | 0.28008204 |
| 87 | ABL1 | 0.27219646 |
| 88 | GRK5 | 0.26960899 |
| 89 | OXSR1 | 0.26317522 |
| 90 | CDK4 | 0.25899229 |
| 91 | MAPK12 | 0.25603319 |
| 92 | EPHB1 | 0.25511204 |
| 93 | SIK2 | 0.25251127 |
| 94 | ADRBK1 | 0.24601881 |
| 95 | INSRR | 0.20443497 |
| 96 | MAP3K3 | 0.19460981 |
| 97 | PASK | 0.18549857 |
| 98 | CDK19 | 0.18213315 |
| 99 | EIF2AK2 | 0.17713148 |
| 100 | MAPK3 | 0.17440070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.32794921 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.74350492 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.27746292 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 4.22655125 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.53302376 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.40248326 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.99491008 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.74630226 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.63245048 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.59976373 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.52608919 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.47401621 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.39704168 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.32008211 |
| 15 | Measles_Homo sapiens_hsa05162 | 2.17625468 |
| 16 | Proteasome_Homo sapiens_hsa03050 | 2.13565146 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.98706982 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.80492037 |
| 19 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.74753239 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.66891850 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.66561134 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.60337756 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.55722256 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.43816585 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.35784152 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.34608407 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.23824809 |
| 28 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.21640811 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17880679 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17162277 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16188307 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.09086346 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.03950456 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00495073 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 0.97648990 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 0.96560520 |
| 37 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89760754 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.89620645 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.87649600 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84826916 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84227594 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 0.83695954 |
| 43 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.83142612 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 0.82572470 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 0.71220992 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63610839 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61565820 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60973785 |
| 49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59466563 |
| 50 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57709976 |
| 51 | Protein export_Homo sapiens_hsa03060 | 0.57125759 |
| 52 | RNA polymerase_Homo sapiens_hsa03020 | 0.53338834 |
| 53 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.52175556 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 0.51309639 |
| 55 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.50964504 |
| 56 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.50465893 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.49404805 |
| 58 | Phototransduction_Homo sapiens_hsa04744 | 0.47399292 |
| 59 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.45919360 |
| 60 | Parkinsons disease_Homo sapiens_hsa05012 | 0.42732424 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36447625 |
| 62 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.36393553 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.35880460 |
| 64 | Phagosome_Homo sapiens_hsa04145 | 0.34803865 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33015066 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.32622225 |
| 67 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32439231 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.25554992 |
| 69 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.24764395 |
| 70 | RNA degradation_Homo sapiens_hsa03018 | 0.19369460 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.18581622 |
| 72 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.18225322 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.18172734 |
| 74 | Homologous recombination_Homo sapiens_hsa03440 | 0.16824752 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.15502503 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.15194059 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.14005461 |
| 78 | Peroxisome_Homo sapiens_hsa04146 | 0.13746089 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.13690115 |
| 80 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.12937449 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.11723951 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.10277120 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.10133736 |
| 84 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.08234126 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.08224122 |
| 86 | Lysosome_Homo sapiens_hsa04142 | 0.07878007 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.07517935 |
| 88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.07301494 |
| 89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.05987450 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.05956389 |
| 91 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.05594930 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.05022205 |
| 93 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.03778374 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.03772598 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.02196230 |
| 96 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.01800546 |
| 97 | Non-small cell lung cancer_Homo sapiens_hsa05223 | -0.0470053 |
| 98 | p53 signaling pathway_Homo sapiens_hsa04115 | -0.0384162 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | -0.0277393 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.0072556 |

